3-Bromo-5-iodopyridin-2-ol

Catalog No. :
ACNRMX102
CAS No. :
637348-81-3
Molecular Formula :
C5H3BrINO
Molecular Weight :
299.89

IUPAC Name:3-bromo-5-iodopyridin-2-ol

3-Bromo-5-iodopyridin-2-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$139.00Login to see priceIn stockInquiry
10g95%$205.00Login to see priceIn stockInquiry
25g95%$410.00Login to see priceIn stockInquiry
100g95%$1607.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-5-iodopyridin-2-ol
IUPAC Name3-bromo-5-iodopyridin-2-ol
MDL No.MFCD11044276
Molecular FormulaC5H3BrINO
Molecular Weight299.89
SMILESOC1=NC=C(I)C=C1Br
InChI KeyGUCOEKKQKHACCX-UHFFFAOYSA-N
Synonym3-BROMO-2-HYDROXY-5-IODOPYRIDINE | DTXSID50698895 | GUCOEKKQKHACCX-UHFFFAOYSA-N | FT-0739746 | Z1269234992 | 3-Bromo-5-iodopyridin-2-ol | DS-14653 | EN300-3181426 | A868049 | MFCD11044276 | 2-Hydroxy-3-bromo-5-iodopyridine | SCHEMBL2374756 | A1-03395 | SY
CAS No.637348-81-3
PubChem CID53425516

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACNRMX102 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDETX276 route compound structure diagram
    ACDETX27613466-43-8 In Stock
  2. Then
  3. ACNRMX102 route product structure diagram
    ACNRMX102637348-81-3 In Stock
Inquiry

2. ACNRMX102 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWTZR230 route compound structure diagram
    ACWTZR230516-12-1 In Stock
  4. Plus
  5. ACDETX276 route compound structure diagram
    ACDETX27613466-43-8 In Stock
  6. Then
  7. ACNRMX102 route product structure diagram
    ACNRMX102637348-81-3 In Stock
Inquiry

Comments (0)